ScinnoHub Pharmaceutical Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: SNH-119014 · Non-transfusion-dependent Thalassemia (NTDT) Primary completion pushed from Mar 29, 2027 to Sep 30, 2027
- Notable: BT-114143 Injection · Abnormal Uterine Bleeding Primary completion pushed from Sep 23, 2025 to Apr 28, 2026
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 2 | 2 |
Disease areas by active trials
Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Thalassemia (1)
Get alerts when ScinnoHub Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.